Cardiol Therapeutics Inc (CRDL) concluded trading on Thursday at a closing price of $1.48, with 3.49 million shares of worth about $5.17 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 60.18% during that period and on Thursday the price saw a gain of about 42.31%. Currently the company’s common shares owned by public are about 64.04M shares, out of which, 62.09M shares are available for trading.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 2 times over the past 12 months. They bought 50,245 shares in 2 of the transactions. In 0 selling transactions, insiders dumped 0 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
However, the stock later moved at a day high price of 1.4800, or with a gain of 42.31%. Stock saw a price change of 37.04% in past 5 days and over the past one month there was a price change of 45.10%. Year-to-date (YTD), CRDL shares are showing a performance of 75.52% which increased to 169.09% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.45 but also hit the highest price of $1.43 during that period. The average intraday trading volume for Cardiol Therapeutics Inc shares is 173.67K. The stock is currently trading 28.98% above its 20-day simple moving average (SMA20), while that difference is up 46.13% for SMA50 and it goes to 66.55% higher than SMA200.
Cardiol Therapeutics Inc (NASDAQ: CRDL) currently have 64.04M outstanding shares and institutions hold larger chunk of about 10.64% of that.
The stock has a current market capitalization of $96.36M and its 3Y-monthly beta is at 0.97. It has posted earnings per share of -$0.32 in the same period. It has Quick Ratio of 5.29 while making debt-to-equity ratio of 0.01. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CRDL, volatility over the week remained 11.14% while standing at 9.99% over the month.
Analysts are in expectations that Cardiol Therapeutics Inc (CRDL) stock would likely to be making an EPS of $Charles River Laboratories Inte in the current quarter, while forecast for next quarter EPS is $245.40 and it is $Stocks for next year. For the current quarter EPS, analysts have given the company a lowest target $CLDL which is $Credo Technology Group Holding at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of $Cardiol Therapeutics Inc. in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 11.00% while it is estimated to decrease by -2.40% in next year.
